Adverse Effects

Biomarkers

Brain Cancer

HER2-Positive Breast Cancer

Triple-Negative Breast Cancer

Breast Cancer

Colorectal Cancer

Esophageal Cancer

Gastric Cancer

Liver Cancer

Pancreatic Cancer

Gastrointestinal Cancer

Bladder Cancer

Kidney Cancer

Prostate Cancer

Genitourinary Cancers

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Gynecologic Cancers

Head & Neck Cancer

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Hematologic Oncology

Hormone-related Cancers

Immunotherapy

Vaccines

Infection

Leukemia

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Lung Cancer

Hodgkin Lymphoma

Lymphoma

Melanoma

Mesothelioma

Neuroendocrine Tumors

Oncology

Pediatric Cancers

Radiation Oncology

Sarcoma

Screening

Skin Cancer & Melanoma

Surgery

Thyroid Cancer

News

Clinical Topics

Global Bulletin

All News

Approval Alert

Media

2 Minute Drill

Around the Practice

Between the Lines

Breaking Barriers

Face Off

From All Angles

Meeting of the Minds

Morning Rounds

OncView

Podcasts

Readout 360

Training Academy

Treatment Algorithms with the Oncology Brothers

Conferences

Publications

All Journals

Editorial Board

For Authors

Year in Review

Events

Frontline Forum

Satellite Sessions

CME/CE

Resources

Contemporary Concepts

Awareness Month

Interactive Tools

Nurse Practitioners/Physician's Assistants

Partners

Career Center

Subscribe

Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.

About

Advertise

CureToday.com

OncLive.com

OncNursingNews.com

TargetedOnc.com

Editorial

Contact

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Cancer Network

Facebook

LinkedIn

Spotlight

Around the Practice 

Journal

Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice

Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer

Clinical

Acute Myeloid Leukemia

Genitourinary Cancer

Gynecologic Cancer

Hematology

Skin Cancer

1rem

View

Upper GI Cancer Treatment Algorithm

Video Series

Adjuvant Nivolumab in Gastric Cancers & CheckMate 8HW

Videos

Panelists discuss how recent clinical trials have revolutionized treatment paradigms for gastrointestinal cancers, shaping evidence-based approaches that optimize patient outcomes through targeted therapies, immunotherapies, and multimodal treatment strategies.

Esophageal/Gastric Adenocarcinoma Standard of Care

Panelists discuss how they incorporate nivolumab into clinical practice, highlighting specific patient characteristics, biomarkers, and disease features that predict favorable responses to this immunotherapy agent.

Adjuvant Nivolumab in Gastric Cancers and CheckMate 8HW

Panelists discuss how multidisciplinary approaches, molecular profiling, and recent advances in targeted therapies and immunotherapy have transformed the management landscape for patients with metastatic gastric adenocarcinoma.

Gastric Adenocarcinoma: Current Treatment Landscape

Panelists discuss how multidisciplinary strategies incorporating chemotherapy, targeted agents, and immunotherapy are strategically sequenced to optimize outcomes for patients with advanced metastatic gastric adenocarcinoma.

Advanced Metastatic Gastric Adenocarcinoma: Treatment Approaches

Panelists discuss how second-line treatments for gastric adenocarcinoma provide survival advantages, improved quality of life, and opportunities for personalized therapy based on molecular profiling and prior treatment response.

Second-Line Treatment for Gastric Adenocarcinoma

Adjuvant Nivolumab in Gastric Cancers and CheckMate 8HW

EP: 1.Esophageal/Gastric Adenocarcinoma Standard of Care

EP: 2.Adjuvant Nivolumab in Gastric Cancers and CheckMate 8HW

EP: 3.Gastric Adenocarcinoma: Current Treatment Landscape

EP: 4.Advanced Metastatic Gastric Adenocarcinoma: Treatment Approaches

EP: 5.Second-Line Treatment for Gastric Adenocarcinoma

Newsletter